decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / CYTOGENETIC_STUDIES
Subscribe or sign in to view the full article.
Article Overview
This article covers the Medicare National Coverage Determinations guidance for cytogenetic studies and the broad clinical situations in which these tests are addressed. It is useful for coding and billing staff, compliance teams, and clinicians who need to understand the coverage scope for chromosome-based diagnostic testing under Medicare policy. The content focuses on the manual’s coverage context, effective date, and the general condition categories referenced in the policy.
Why This Topic Matters
Coverage determinations can affect whether cytogenetic testing is considered payable and help stakeholders align documentation, ordering practices, and claim review with Medicare policy.
What You Will Learn
- The Medicare coverage context for cytogenetic studies
- The general categories of clinical situations referenced in the coverage guidance
- The effective date associated with the policy language
- How this manual entry is positioned within Medicare coverage documentation
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Laboratory administrators
- Clinicians ordering genetic testing
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com